Citation Impact
Citing Papers
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
2003 Standout
Dendritic cell–expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice
2007 StandoutNobel
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas
2006
Tumor irradiation enhances the tumor-specific distribution of poly(L-glutamic acid)-conjugated paclitaxel and its antitumor efficacy.
2000
Four-component protein nanocages designed by programmed symmetry breaking
2024 StandoutNatureNobel
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin
2002
Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer
2004
Population pharmacokinetics in phase I drug development: a phase I study of PK1 in patients with solid tumours
1999
Phase I and pharmacokinetic (PK) study of MAG-CPT (PNU 166148): a polymeric derivative of camptothecin (CPT)
2004
Asialoglycoprotein receptor mediated hepatocyte targeting — Strategies and applications
2015
Poly(amidoamine)s as Potential Endosomolytic Polymers: EvaluationIn Vitroand Body Distribution in Normal and Tumour-Bearing Animals
1999
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
The Nonobese Diabetic Mouse as a Model of Autoimmune Diabetes: Immune Dysregulation Gets the NOD
1997
Multifunctional Lipid/Quantum Dot Hybrid Nanocontainers for Controlled Targeting of Live Cells
2006 StandoutNobel
Protein‐Based Nanomedicine Platforms for Drug Delivery
2009
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470
2004
HPMA Copolymers Platinates Containing Dicarboxylato Ligands. Preparation, Characterisation and In Vitro and In Vivo Evaluation
2002
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumours
2004
PDEPT: polymer-directed enzyme prodrug therapy
2001
Polymer-drug conjugates: Recent development in clinical oncology
2008
Imaging in the era of molecular oncology
2008 StandoutNature
Prodrug Strategies in Anticancer Chemotherapy
2007
Rationally Designed Chemical Modulators Convert a Bacterial Channel Protein into a pH‐Sensory Valve
2006 StandoutNobel
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells
1999 Nature
Tissue Destruction by Neutrophils
1989 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting
2001 Standout
Polymeric anticancer drugs with pH-controlled activation
2004
Nanotheranostics ˗ Application and Further Development of Nanomedicine Strategies for Advanced Theranostics
2014
HPMA copolymer–anticancer drug conjugates: design, activity, and mechanism of action
2000
A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells
2014 StandoutNobel
Polymer conjugates as anticancer nanomedicines
2006 Standout
Stimulated Release of Size‐Selected Cargos in Succession from Mesoporous Silica Nanoparticles
2012 StandoutNobel
In vitro responses of human CD45R0brightRA− and CD45R0−RAbright T cell subsets and their relationship to memory and naive T cells
1997
Dendrimer biocompatibility and toxicity
2005
Polymer Therapeutics Designed for a Combination Therapy of Hormone‐Dependent Cancer
2005
Direct In Vivo Xenograft Tumor Model for Predicting Chemotherapeutic Drug Response in Cancer Patients
2008
Phase I Study of CT-2103, A Polymer-Conjugated Paclitaxel, and Carboplatin in Patients with Advanced Solid Tumors
2005
Progress of drug-loaded polymeric micelles into clinical studies
2014
Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: Concepts and applications
2012
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression
1998 StandoutNature
Polymer-Based Cancer Nanotheranostics: Retrospectives of Multi-Functionalities and Pharmacokinetics
2013
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
HPMA copolymers: Origins, early developments, present, and future☆
2009
Application of Nanotechnology in Cancer Therapy and Imaging
2008
HPMA copolymer platinates as novel antitumour agents: in vitro properties, pharmacokinetics and antitumour activity in vivo
1999
Polymer–drug conjugates: towards a novel approach for the treatment of endrocine-related cancer
2005
Pancreatic Cancer
2010 Standout
Ligand-targeted therapeutics in anticancer therapy
2002
Extracellular mRNA Induces Dendritic Cell Activation by Stimulating Tumor Necrosis Factor-α Secretion and Signaling through a Nucleotide Receptor
2002 StandoutNobel
Development of HPMA copolymer–anticancer conjugates: Clinical experience and lessons learnt
2009
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
2000 Standout
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine
2012
Organic Switches for Surfaces and Devices
2012 StandoutNobel
Poly-(L)-Glutamic Acid-Paclitaxel (CT-2103) [XYOTAX™], a Biodegradable Polymeric Drug Conjugate
2004
Polymer–drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic
2001
Molecular imaging in drug discovery and development
2003
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
2011
Receptor-targeted nanocarriers for therapeutic delivery to cancer
2010
The dawning era of polymer therapeutics
2003 Standout
Water soluble polymers in tumor targeted delivery
2001
Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes
2005 StandoutNobel
Theranostic Nanomedicine
2011
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Preclinical evaluation of the cardiotoxicity of PK2: A novel HPMA copolymer–doxorubicin–galactosamine conjugate antitumour agent
2001
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery
2006
Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles
2013 StandoutNobel
Therapeutic Nanoparticles for Drug Delivery in Cancer
2008 Standout
Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Regulates the Unfolding of Autoimmune Diabetes
1998 StandoutNobel
Cytostatic and immunomobilizing activities of polymer-bound drugs: experimental and first clinical data
2003
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Intracellular Delivery of a Proapoptotic Peptide via Conjugation to a RAFT Synthesized Endosomolytic Polymer
2009
Nonviral Vectors for Gene Delivery
2008 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
The effect of particle design on cellular internalization pathways
2008 Standout
A role for fungal β-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice
2005 StandoutNobel
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Gadolinium-Based Hybrid Nanoparticles as a Positive MR Contrast Agent
2006
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
2002
Designing polymer conjugates as lysosomotropic nanomedicines
2007
Oxygen Radicals and Human Disease
1987 Standout
Checkpoints in the progression of autoimmune disease: lessons from diabetes models.
1996
GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
2018
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Enzyme-Responsive Snap-Top Covered Silica Nanocontainers
2008 StandoutNobel
Cloning and characterization of a functional human homolog of Escherichia coli endonuclease III
1997 StandoutNobel
Synthesis and Characterization of AP5346, a Novel Polymer-Linked Diaminocyclohexyl Platinum Chemotherapeutic Agent
2006
CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune Diabetes
2004 StandoutNobel
Thermogelling Polymer–Platinum(IV) Conjugates for Long-Term Delivery of Cisplatin
2014
Polyester Dendritic Systems for Drug Delivery Applications: In Vitro and In Vivo Evaluation
2002
Metal–Organic Frameworks in Biomedicine
2011 Standout
pH-Operated Nanopistons on the Surfaces of Mesoporous Silica Nanoparticles
2010 StandoutNobel
Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies
2016
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
HPMA copolymer–aminoglutethimide conjugates inhibit aromatase in MCF-7 cell lines
2005
Atomically Precise Clusters of Noble Metals: Emerging Link between Atoms and Nanoparticles
2017 Standout
Works of S S Burtles being referenced
Cancer Research UK procedures in manufacture and toxicology of radiotracers intended for Pre-phase I positron emission tomography studies in cancer patients
2002
Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics
1999
Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
2002
Preclinical toxicology of a novel polymeric antitumour agent: HPMA copolymerdoxorubicin (PK1)
1998
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.
1999
Absence of T cell tolerance to pancreatic islet cells.
1992
Primary and secondary human in vitro T-cell responses to soluble antigens are mediated by subsets bearing different CD45 isoforms.
1992
Erythrocyte antioxidant enzymes in multiple sclerosis and the effect of hyperbaric oxygen
1984